- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02244905
Trial of Positive Deviance in Inpatient Wards to Reduce Hospital Infections
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Objective: To evaluate whether positive deviance (PD) based horizontal infection prevention approach will result in a higher rate of decline in incidence density of patients with HAI (central line-associated bloodstream infection, healthcare-associated pneumonia, catheter-associated urinary tract infection, or Clostridium difficile infection) per 1000 patient days per month in the intervention wards compared to control wards.
Design: A cluster randomized controlled trial was conducted over a period of 24 months. Six medical wards were randomized and positive deviance intervention was randomly allocated to one of the two groups of three wards each. The baseline, intervention and follow-up periods were 6, 9 and 9 months respectively.
Setting: A public safety-net major teaching hospital in United States.
Participants: The ward staffs participated in the intervention.
Intervention: Key components of the intervention were invitation to participate voluntarily, open-ended dialogues with staff members to discover barriers and seek solutions to prevent HAI, discussion of outcomes, and encouragement to prioritize and implement the solutions generated. Staffs of all six wards were asked to voluntarily participate in a modified hospital survey of patient safety climate (HSOPSC) and a social network survey at 6, 15, and 24 months.
Statistical analysis: Statistical methods used were time series modeling, summary of frequencies, Chi-square or Fisher's exact for testing difference in proportions and t-test.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
The intervention was performed on the staff members providing care in the three wards belonging to the intervention arm of the study. These staff members were invited to participate in the positive deviance intervention on a voluntary and anonymous basis.
The primary outcome was measured in all the patients who received care in the three intervention wards and the three control wards.
Inclusion Criteria:
- For Intervention: All staff members employed in the study wards assigned to the intervention arm.
For Primary Outcome Assessment:
- All patients admitted to any of the six study wards included in the study over the 24-month study period.
Exclusion Criteria:
-None
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Positive Deviance Intervention Arm
Three hospital wards received Positive Deviance intervention.
|
The recipients of the Positive Deviance intervention are the staff members of the three wards in the intervention arm, while the outcomes are measured among the patients receiving care in the three wards in the intervention arm.
Key components of the intervention were invitation to participate voluntarily, open-ended dialogues with staff members to discover barriers and seek solutions to prevent HAI, discussion of outcomes, and encouragement to prioritize and implement the solutions generated.
Standard-of-Care Infection Control approach
|
|
Other: Control Arm
Three hospital wards randomized to control arm received the Standard-of-Care Infection Control approach.
|
Standard-of-Care Infection Control approach
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of HAI per 1000 patient-days per month.
Time Frame: 24 Months
|
The primary study outcome is the incidence density of HAI [a composite of central line associated bloodstream infection (CLABSI), hospital-acquired pneumonia (HAP), catheter-associated urinary tract infection (CAUTI) and C.difficile infection (CDI)] per 1000 patient-days per month.
|
24 Months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Pranavi Sreeramoju, MD, UT Southwestern Medical Center
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- STU 072011-079
- Grant # 137911 (Other Identifier: University of Texas System Patient Safety)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthcare-associated Infections
-
Universidad Autonoma de Nuevo LeonUnknownHealthcare Associated Infections
-
Giovanna Marssola NascimentoMinistry of Health, BrazilCompletedHealthcare-Associated Pneumonia | Ventilator-Associated Pneumonia | Healthcare Associated InfectionBrazil
-
University of MichiganAgency for Healthcare Research and Quality (AHRQ)CompletedHealthcare-Associated InfectionsUnited States
-
Biocruces Bizkaia Health Research InstituteHospital General Universitario Gregorio Marañon; Germans Trias i Pujol Hospital and other collaboratorsRecruitingHealthcare-associated Infections | Pneumonia Neonatal | Pneumonia Ventilator AssociatedSpain
-
Far Eastern Memorial HospitalCompletedHealthcare Associated PneumoniaTaiwan
-
Vanderbilt UniversityCompletedHealthcare Associated InfectionsUnited States
-
Duke UniversityCompletedHealthcare Associated Infections | Multidrug Resistant OrganismsUnited States
-
ShionogiCompletedHospital Acquired Pneumonia (HAP) | Healthcare-associated Pneumonia (HCAP) | Ventilator Associated Pneumonia (VAP)Israel, Spain, United States, Belgium, Canada, Czechia, Estonia, France, Georgia, Germany, Hungary, Japan, Latvia, Philippines, Puerto Rico, Russian Federation, Serbia, Taiwan, Ukraine
-
Kaohsiung Medical University Chung-Ho Memorial...CompletedAccuracy | Healthcare-associated Infections | ComplianceTaiwan
-
University Hospital, LilleNot yet recruitingPneumonia, Ventilator-Associated Healthcare-associated Pneumonia Respiration, Artificial
Clinical Trials on Positive Deviance
-
Universiti Putra MalaysiaCompletedMalnutrition, ChildMalaysia
-
Makerere UniversityCompleted
-
The University of Texas Health Science Center at...Completed
-
Oregon Health and Science UniversityCompleted
-
University of Central FloridaCompleted
-
University of Central FloridaEnrolling by invitation
-
Fondazione Policlinico Universitario Agostino Gemelli...CompletedSleep Apnea, Obstructive | Fatigue | SarcoidosisItaly
-
University of Illinois at Urbana-ChampaignNational Heart, Lung, and Blood Institute (NHLBI)UnknownCardiovascular Risk Factor | Uncontrolled HypertensionUnited States
-
Hospital Israelita Albert EinsteinFundação de Amparo à Pesquisa do Estado de São PauloUnknownRespiratory Distress SyndromeBrazil
-
University of VirginiaUniversity of Florida; Wake Forest University Health SciencesRecruitingObesity (Disorder) | Obesity & OverweightUnited States